NCT06857708View on ClinicalTrials.gov

The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 5, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

December 31, 2026

Conditions
Necrotizing FascitisNecrotizing Soft Tissue Infection
Interventions
DEVICE

Cytal® Wound Matrix

This is the only study to use this intervention in necrotizing soft tissue wounds

DEVICE

MicroMatrix®

This is the only study to use this intervention in necrotizing soft tissue wounds

Trial Locations (1)

44195

RECRUITING

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

Benjamin T. Miller

OTHER